Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-002046
Filing Date
2025-01-08
Accepted
2025-01-08 16:30:11
Documents
1
Period of Report
2025-01-06

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm252665-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm252665-1_4seq1.xml 4 6625
  Complete submission text file 0001104659-25-002046.txt   8191
Mailing Address C/O RESEARCH PHARMACEUTICAL SERVICES,INC 520 VIRGINIA DRIVE FORT WASHINGTON PA 19034
Business Address
DEAN JACK H (Reporting) CIK: 0001434978 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40536 | Film No.: 25518878

Mailing Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305
Business Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305 917-533-1469
Acurx Pharmaceuticals, Inc. (Issuer) CIK: 0001736243 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)